Page 487 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

16. ANTHRACYCLINES • PERSPECTIVES 445

BOOSER D.J. et al., Phase I study of liposomal annamycin, CancerChemother. Pharma-
col., 2000, 46, 427-432.
CASSIDY J., Polymer-directed enzyme prodrug therapy, Orugs News Perspect., 2000,
13, 477-480.
LEHNE G., P-glycoprotein as a drug target in the treatment of multidrug resistant cancer,
Current Drug Targets, 2000, 1, 85•89.
MONNERET C., FLORÉNT J. , Ciblage de molécules antitumorales par les anticorps
monoclonaux, Bull. Cancer, 2000, 87, 829-838.
HABECK M., Cancer drug delivery is hot stuff, Orug Oiscovery To-day, 2001, 6, 754-756.
PHARMACOMUDULATION
MARSCHALK C. et al., Nouvelle méthode d'introduction des chaines latérales dans le
noyau anthraquinonique, Bull. Soc. Chim. Fr. Mem., 1936, 3, 1545-1575.
ECKLE E. et al., The crystal and molecular structure of 7-con-O-methylnogarol, Tetrahe-
dron Letters, 1980, 21, 507-510.
AD 32, Drugs Future, 1980, 5, 171-173; 1977, 22,413; 1999, 24,442.
Menogaril, Drugs Future, 1980, 5, 400-402; 1996, 21,840; 1997, 22, 911-912.
KERDESKY F.A.J., Simple o-quinodimethane route to (±)-4-demethoxydaunomycinone,
J. Am. Chem. Soc., 1981, 103, 1992-1996.
ARDECKY R. J. et al., 3-(Acyloxy)-3-buten-2-ones as dienophiles in anthracyclinone syn-
thesis. An efficient route to 4-demethoxy-7-deoxydaunomycine, J. Org. Chem., 1982,
47, 409-412.
STREETER D. G. et al., Uptake and retention of morpholinyl anthracyclines by adriamy-
cin-sensitive and - resistant P388 cells, Cancer Chemother. Pharmacof., 1986, 16,
247-252.
NADHESTANI A.N., FCE-21954, I-DOX, Drugs Future, 1987, 12, 849-850 ; 1990, 15, 951-
952 ; 1991, 16, 859-860 ; 1992, 17, 845 ;1993, 18, 862 ; 1994, 19, 875 ;1995,20,947.
Amrubicine, Orugs Future, 1988, 13, 962-966 ; 1997, 22, 1271-1272 ; 1998, 23, 1232-
1233 ; 1999, 24, 1256-1257.
Morpholino-oxaunomycine, MX2, Orugs Future, 1988, 13, 923-925 ; 1997, 22, 1168
CABANILLAS F., Menogaril, Orugs Future, 1990, 5, 400-402.
VEENEMAN G. H., Van BOOM J. H., An efficient thioglycoside-mediated formation of CL-
glycosidic linkages promoted by iodonium dicollidine perchlorate, Tetrahedron, 1990,
31, 275-278.
SMID P. et al., lodonium assisted stereospecific glycosylation: synthesis of oligosac-
charides containing a(1-4)-linked L-fucopyranosyl units, J. Carbohydr. Chem., 1991,
10, 833-849.
YAMASHITA Y. etal., Induction of mammalian DNA toposisomerase I and II mediated
DNA cleavage by saintopin, a new antitumor agent from fungus, Biochemistry, 1991,
30, 5838-5845.
LAU D.H.M. et al., Characterization of covalent DNA binding of morpholino and cyano-
morpholino derivatives of doxorubicin, J. Natl. Cancer Inst., 1992, 84, 1587-1592.
LEWIS A. O. et al., Role of cytochrome P-450 from the human CYP3A gene family in the
potentiation of morpholino-doxorubicin by human liver microsomes, Cancer Res.,
1992, 52, 4379-4384.